251 related articles for article (PubMed ID: 23721522)
1. Gastroprotective and anti-Helicobacter pylori potential of herbal formula HZJW: safety and efficacy assessment.
Xie JH; Chen YL; Wu QH; Wu J; Su JY; Cao HY; Li YC; Li YS; Liao JB; Lai XP; Huang P; Su ZR
BMC Complement Altern Med; 2013 May; 13():119. PubMed ID: 23721522
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of safety of modified-Danggui Buxue Tang in rodents:immunological, toxicity and hormonal aspects.
Xie JH; Chen ZW; Pan YW; Luo DM; Su ZR; Chen HM; Qin Z; Huang SQ; Lei G
J Ethnopharmacol; 2016 May; 183():59-70. PubMed ID: 26732632
[TBL] [Abstract][Full Text] [Related]
3. Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial.
Feng LY; Yao XX; Jiang SL
World J Gastroenterol; 2005 Feb; 11(7):1083-6. PubMed ID: 15742421
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
Andreev DN; Maev IV; Dicheva DT; Samsonov AA; Partzvania-Vinogradova EV
Ter Arkh; 2018 Aug; 90(8):27-32. PubMed ID: 30701936
[TBL] [Abstract][Full Text] [Related]
6. Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients.
Felga G; Silva FM; Barbuti RC; Navarro-Rodriguez T; Zaterka S; Eisig JN
J Infect Dev Ctries; 2010 Nov; 4(11):712-6. PubMed ID: 21252448
[TBL] [Abstract][Full Text] [Related]
7. [Effect of birid triple viable on peptic ulcer patients with Helicobacter pylori infection].
Xu C; Xiao L; Zou H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 35(9):1000-4. PubMed ID: 20871168
[TBL] [Abstract][Full Text] [Related]
8. Three treatment schemes with colloidal bismuth subcitrate (Q-ULCER) in peptic ulcer with Helicobacter pylori.
Suárez MS; González Cansino J; Velasco Ilizalde C; Sabatier CA; Castillo Hernández J
Arch Med Res; 1999; 30(1):55-9. PubMed ID: 10071426
[TBL] [Abstract][Full Text] [Related]
9. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial effect of Kampo herbal formulation Hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang) on Helicobacter pylori infection in mice.
Yan X; Kita M; Minami M; Yamamoto T; Kuriyama H; Ohno T; Iwakura Y; Imanishi J
Microbiol Immunol; 2002; 46(7):475-82. PubMed ID: 12222933
[TBL] [Abstract][Full Text] [Related]
13. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.
Bochenek WJ; Peters S; Fraga PD; Wang W; Mack ME; Osato MS; El-Zimaity HM; Davis KD; Graham DY;
Helicobacter; 2003 Dec; 8(6):626-42. PubMed ID: 14632678
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of the dosing regimen of pantoprazole 40 mg, amoxicillin 1000 mg and clarithromycin 500 mg, twice daily for 7 days, in the eradication of Helicobacter pylori in patients with peptic ulcer].
Coelho LG; Mattos AA; Francisconi CF; Castro Lde P; André SB
Arq Gastroenterol; 2004; 41(1):71-6. PubMed ID: 15499429
[TBL] [Abstract][Full Text] [Related]
15. Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial.
Kaviani MJ; Malekzadeh R; Vahedi H; Sotoudeh M; Kamalian N; Amini M; Massarrat S
Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):915-9. PubMed ID: 11507355
[TBL] [Abstract][Full Text] [Related]
16. Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer disease.
Felga GE; Silva FM; Barbuti RC; Navarro-Rodriguez T; Zaterka S; Eisig JN
World J Gastroenterol; 2008 Oct; 14(40):6224-7. PubMed ID: 18985815
[TBL] [Abstract][Full Text] [Related]
17. Brazilian medicinal plant acts on prostaglandin level and Helicobacter pylori.
Lima ZP; Calvo TR; Silva EF; Pellizzon CH; Vilegas W; Brito AR; Bauab TM; Hiruma-Lima CA
J Med Food; 2008 Dec; 11(4):701-8. PubMed ID: 19053863
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of ranitidine bismuth citrate with clarithromycin for seven days in the eradication of Helicobacter pylori in Brazilian peptic ulcer patients.
Eisig JN; Silva FM; Hashimoto C; Chehter EZ; Laudanna AA
Sao Paulo Med J; 2003 Jan; 121(1):15-8. PubMed ID: 12751338
[TBL] [Abstract][Full Text] [Related]
19. Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients?
Annibale B; D'Ambra G; Luzzi I; Marcheggiano A; Iannoni C; Paoletti M; Anania MC; Marignani M; Delle Fave G
Am J Gastroenterol; 1997 May; 92(5):790-4. PubMed ID: 9149186
[TBL] [Abstract][Full Text] [Related]
20. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
Ji KY; Hu FL
World J Gastroenterol; 2006 Jun; 12(24):3789-92. PubMed ID: 16804960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
